Shankar Sellappan

Jul 26, 2024 | bioprocessintl.com | Derrick Zhang |Shankar Sellappan |Brian Gazaille |Eric Bishop

Host cell proteins (HCPs) have become particularly notorious among process-related impurities. Purification workflows generally yield highly pure drug substances, and the biopharmaceutical industry has a strong track record of ensuring patient safety. However, some HCPs are known to coelute with therapeutic proteins into drug substances.

Jun 12, 2024 | bioprocessintl.com | Derrick Zhang |Shankar Sellappan

Sep 23 - Sep 26, 2024Learn from the brightest minds in bioprocessing!The BPI US 2024 scientific agenda includes 200+ of the industry's top scientists to present the latest updates on how to improve efficiencies across all phases of biopharmaceutical development and production. Learn More

Jun 11, 2024 | bioprocessintl.com | Shankar Sellappan |Derrick Zhang

Sep 23 - Sep 26, 2024Learn from the brightest minds in bioprocessing!The BPI US 2024 scientific agenda includes 200+ of the industry's top scientists to present the latest updates on how to improve efficiencies across all phases of biopharmaceutical development and production. Learn More